SCHEMBL22660

SCHEMBL22660

Nc1ccc2c(c1)CC(=O)N2

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AHR P35869 4/20 0.61
CA9 Q16790 1/20 0.55
PDE3B Q13370 1/20 0.54
PDE3A Q14432 1/20 0.54
GRIA1 P42261 2/20 0.54
CACNG8 Q8WXS5 2/20 0.54
PDK2 Q15119 1/20 0.53
EPHX2 P34913 1/20 0.51
PGR P06401 3/20 0.50
TDP2 O95551 1/20 0.49
SMYD3 Q9H7B4 3/20 0.48
CYP1A2 P05177 1/20 0.47
CYP11B1 P15538 1/20 0.47
CYP11B2 P19099 1/20 0.47
CMA1 P23946 2/20 0.47
GAA P10253 1/20 0.46
EIF2AK2 P19525 1/20 0.46
HDAC3 O15379 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9824774 0.98 AHR (0.59) AHRCA9PDE3BPDE3AGRIA1
Hydrochloric Acid SCHEMBL15206761 0.98 AHR (0.59) AHRCA9PDE3BPDE3AGRIA1
SCHEMBL10711906 0.87 PDE3B (0.68) AHRPDE3BPDE3AGRIA1CACNG8
SCHEMBL8198247 0.84 PGR (0.61) AHRPDE3BPDE3AGRIA1CACNG8
SCHEMBL398137 0.84 CA9 (0.70) AHRCA9PDE3BPDE3AGRIA1
SCHEMBL30468520 0.84 CA9 (0.70) AHRCA9PDE3BPDE3AGRIA1
SCHEMBL9471753 0.83 MAPT (0.52) AHRCA9PDE3BPDE3AGRIA1
Hydrochloric Acid SCHEMBL9833199 0.82 CA9 (0.68) AHRCA9PDE3BPDE3AGRIA1
SCHEMBL736368 0.82 CA9 (0.73) CA9PDE3BPDE3ASMYD3CYP1A2
SCHEMBL10711487 0.82 TDP2 (0.56) AHRCA9PDE3BPDE3AGRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 732 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611797-B1 QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS HANMI SCIENCE CO LTD (KR) 2016-12-28 EP claimed
US-8835458-B2 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells HANMI SCIENCE CO., LTD (KR) 2014-09-16 US claimed
EP-2611797-A2 QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS Hanmi Science Co., Ltd. (KR) 2013-07-10 EP claimed
US-20130165386-A1 QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS HANMI SCIENCE CO., LTD (KR) 2013-06-27 US claimed
WO-2012030160-A2 QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS HANMI HOLDINGS CO., LTD. (KR) 2012-03-08 WO claimed
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines Bayer ScienceCrop AG (DE) 2011-09-22 US claimed
EP-2330904-A2 4-ALKYL-SUBSTITUTED DIAMINOPYRIMIDINES Bayer CropScience AG (DE) 2011-06-15 EP claimed
US-20110105472-A1 Diaminopyrimidines as crop protection agents BAYER CROPSCIENCE AG (DE) 2011-05-05 US claimed
EP-2268144-A2 DIAMINOPYRIMIDINES AS PLANT PROTECTION AGENTS Bayer CropScience AG (DE) 2011-01-05 EP claimed
US-20100081679-A1 DIAMINOPYRIMIDINES AS FUNGICIDES BAYER CROPSCIENCE AG (DE) 2010-04-01 US claimed
EP-2129222-A1 DIAMINOPYRIMIDINES AS FUNGICIDES Bayer CropScience AG (DE) 2009-12-09 EP claimed
WO-2009115267-A2 DIAMINOPYRIMIDINES AS PLANT PROTECTION AGENTS BAYER CROPSCIENCE AG (DE) 2009-09-24 WO claimed
US-20090118316-A1 Methods for Augmenting Bone PFZER INC. 2009-05-07 US claimed
WO-2008107096-A1 DIAMINOPYRIMIDINES AS FUNGICIDES BAYER CROPSCIENCE AG (DE) 2008-09-12 WO claimed
EP-1765461-A1 PYK2 INHIBITORS FOR STIMULATION OF OSTEOBLAST FUNCTION Pharmacia & Upjohn Company LLC (US) 2007-03-28 EP claimed
WO-2005123191-A1 PYK2 INHIBITORS FOR STIMULATION OF OSTEOBLAST FUNCTION PHARMACIA & UPJOHN COMPANY LLC (US) 2005-12-29 WO claimed
US-20040147586-A1 Indolinone derivatives as protein kinase/phosphatase inhibitors SUGEN, INC. 2004-07-29 US claimed
EP-1294688-A2 INDOLINONE DERIVATIVES AS PROTEIN KINASE/PHOSPHATASE INHIBITORS Sugen, Inc. (US) 2003-03-26 EP claimed
US-20020052369-A1 Indolinone derivatives as protein kinase/phosphatase inhibitors SUGEN, INC. 2002-05-02 US claimed
WO-2001094312-A2 INDOLINONE DERIVATIVES AS PROTEIN KINASE/PHOSPHATASE INHIBITORS SUGEN, INC. (US) 2001-12-13 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118316-A1 Methods for Augmenting Bone PTK2, PHKA2, BMP2K AHR 4283/4885CA9 3788/4885PDE3B 1000/4885
US-20100081679-A1 DIAMINOPYRIMIDINES AS FUNGICIDES PM20D2, DDT, DDX41 AHR 1281/4885CA9 707/4885PDE3B 266/4885
US-20110230478-A1 4-Alkyl-substituted diaminopyrimidines DPM1, DPYD, POLR1C AHR 504/4885CA9 2561/4885PDE3B 631/4885
US-20040147586-A1 Indolinone derivatives as protein kinase/phosphatase inhibitors PHKA1, PHKA2, PDPK1 AHR 2554/4885CA9 4364/4885PDE3B 398/4885
US-20130165386-A1 QUINOLINE OR QUINAZOLINE DERIVATIVES WITH APOPTOSIS INDUCING ACTIVITY ON CELLS CASP7, API5, BAX AHR 2298/4885CA9 1473/4885PDE3B 2371/4885
US-20110105472-A1 Diaminopyrimidines as crop protection agents DDX41, DDX1, DDX5 AHR 2612/4885CA9 1421/4885PDE3B 436/4885
US-20020052369-A1 Indolinone derivatives as protein kinase/phosphatase inhibitors PHKA1, PHKA2, PDPK1 AHR 2554/4885CA9 4364/4885PDE3B 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.